Cardiovascular complications of immune checkpoint inhibitors
Cardiovascular toxicity of cancer therapies remains an urgent problem today. The creation of highly effect antitumor drugs also means the appearance of new adverse effects. Immune checkpoint inhibitors (ICI) is a new class of antitumor drugs that is different from traditional chemotherapeutic and ta...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
Izdatelstvo OKI
2020-04-01
|
| シリーズ: | Качественная клиническая практика |
| 主題: | |
| オンライン･アクセス: | https://www.clinvest.ru/jour/article/view/477 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|